Literature DB >> 15905618

Preferential migration of CD62L cells into the appendix in mice with experimental chronic colitis.

S A Farkas1, M Hornung, Christine Sattler, M Steinbauer, M Anthuber, F Obermeier, H Herfarth, H J Schlitt, E K Geissler.   

Abstract

BACKGROUND: Clinical and experimental studies suggest that appendectomy can protect against development of ulcerative colitis and Crohn's disease. However, how T cells in the appendix affect the development of colitis has not been clarified. AIM: To investigate the in vivo migration and activation of colitis-inducing CD62L+ cells during development of chronic colitis.
METHODS: CD62L+CD4+ cells were fluorescently labeled and transferred to severe combined immunodeficient (SCID) mice to induce colitis. In vivo migration of T cells into the mucosa of the appendix and colon was quantified by in vivo microscopy after 7 weeks. In a second experiment, unlabeled CD62L+CD4+ cells were transferred, reisolated after 7 weeks, and adhesion molecule (integrin alpha4beta7) and costimulatory molecule (CD154) expression was analyzed.
RESULTS: Six to eight weeks after CD62L+CD4+ cell transfer, SCID mice developed chronic colitis. In vivo microscopic analysis demonstrated a preferential migration of fluorescence-labeled CD62L+CD4+ cells into the mucosa of the appendix versus the colon. Re-isolation of lamina propria cells from mice with colitis confirmed that CD62L+CD4+ cell migration was significantly enhanced in the appendix, compared to the colon (3.5-fold). Furthermore, a higher proportion of CD62L+CD4+ cells re-isolated from the appendix expressed integrin alpha4beta7 and CD154 than from the colon.
CONCLUSION: This study demonstrates the preferential migration of CD62L+CD4+ cells into the appendix as compared to the colon. This migration pattern correlated with upregulation of integrin alpha4beta7 and CD154 (CD40 ligand) on T cells. Our results suggest an important role of the appendix in the pathogenesis of colitis. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905618     DOI: 10.1159/000084543

Source DB:  PubMed          Journal:  Eur Surg Res        ISSN: 0014-312X            Impact factor:   1.745


  14 in total

1.  Migration and chemokine receptor pattern of colitis-preventing DX5+NKT cells.

Authors:  Matthias Hornung; Jens M Werner; Stefan Farkas; Hans J Schlitt; Edward K Geissler
Journal:  Int J Colorectal Dis       Date:  2011-06-07       Impact factor: 2.571

Review 2.  Experimental appendicitis and appendectomy modulate the CCL20-CCR6 axis to limit inflammatory colitis pathology.

Authors:  Rajkumar Cheluvappa
Journal:  Int J Colorectal Dis       Date:  2014-07-01       Impact factor: 2.571

Review 3.  The immunology of the vermiform appendix: a review of the literature.

Authors:  I A Kooij; S Sahami; S L Meijer; C J Buskens; A A Te Velde
Journal:  Clin Exp Immunol       Date:  2016-07-19       Impact factor: 4.330

4.  Protective pathways against colitis mediated by appendicitis and appendectomy.

Authors:  R Cheluvappa; A S Luo; C Palmer; M C Grimm
Journal:  Clin Exp Immunol       Date:  2011-06-27       Impact factor: 4.330

5.  Endothelin and vascular remodelling in colitis pathogenesis--appendicitis and appendectomy limit colitis by suppressing endothelin pathways.

Authors:  Rajkumar Cheluvappa; Rajaraman Eri; Annie S Luo; Michael C Grimm
Journal:  Int J Colorectal Dis       Date:  2014-08-02       Impact factor: 2.571

Review 6.  The Link between the Appendix and Ulcerative Colitis: Clinical Relevance and Potential Immunological Mechanisms.

Authors:  S Sahami; I A Kooij; S L Meijer; G R Van den Brink; C J Buskens; A A Te Velde
Journal:  Am J Gastroenterol       Date:  2015-09-29       Impact factor: 10.864

7.  Modulation of interferon activity-associated soluble molecules by appendicitis and appendectomy limits colitis-identification of novel anti-colitic targets.

Authors:  Rajkumar Cheluvappa; Rajaraman Eri; Annie S Luo; Michael C Grimm
Journal:  J Interferon Cytokine Res       Date:  2014-09-22       Impact factor: 2.607

8.  A murine model of appendicitis and the impact of inflammation on appendiceal lymphocyte constituents.

Authors:  W S Watson Ng; T Hampartzoumian; A R Lloyd; M C Grimm
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

Review 9.  Appendiceal skip inflammation and ulcerative colitis.

Authors:  Sang Hyoung Park; Edward V Loftus; Suk-Kyun Yang
Journal:  Dig Dis Sci       Date:  2014-04-05       Impact factor: 3.199

10.  T helper type 17 pathway suppression by appendicitis and appendectomy protects against colitis.

Authors:  R Cheluvappa; A S Luo; M C Grimm
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.